Targeting the leukemia–stroma interaction in acute myeloid leukemia: rationale and latest evidence.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 1, p. 40, doi. 10.1177/2040620715619307
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2016 AND VI 7 AND IP 1
Results: 4
1
2
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic).
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 1, p. 17, doi. 10.1177/2040620715616544
- By:
- Publication type:
- Article
3
Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 1, p. 3, doi. 10.1177/2040620715614529
- By:
- Publication type:
- Article
4
Current challenges and novel treatment strategies in double hit lymphomas.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 1, p. 52, doi. 10.1177/2040620715608091
- By:
- Publication type:
- Article